Submissions

Author Guidelines

1. Publication regulations
2. Instructions for authors

 

1. Publication regulations

Any manuscript submitted to Respirar with the intention of being published, whatever its nature, must include the Copyright Form and the Conflict of Interest Form (in which the funding sources are also declared). Only unpublished works will be accepted, manuscripts should not be submitted simultaneously to two or more journals. However, Respirar will accept submissions that come from reliable preprint servers, as well as it will be able to make use of them and allow their use by authors until the time of publication. 

Any manuscript submitted to Respirar will be processed by the iThenticate plagiarism detection system and will then undergo a single blind peer review process. Both policies are detailed in About the journal.

Respirar adheres to the principles of transparency and best practices in academic publishing (Principles of Transparency and Best Practice in Scholarly Publishing) established by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME), and the Singapore Statement on Research Integrity.

Papers that collect data on humans or animals: must be done in accordance with the Declaration of Helsinki (WHO code of ethics) and require the approval of a local ethics committee. The opinion of the ethics committee recognized by the Health Authority or National Health Council (or similar) must be submitted.  If applicable, the authors must also have the informed consent of the study subjects. The inclusion of any type of information that allows the identification of patients will not be accepted.

Clinical trials: must be registered with the Data Providers of the WHO International Clinical Trials Registries Platform (ICTRP), ReBEC (Brazilian Clinical Trials Registry) or similar ones when they have been approved by the national ethics committee and before the selection of patients for the investigation. The name of the database, acronym and/or number of the Clinical Trial must appear at the end of the abstract of the article. Purely observational studies do not require registration.

International guidelines for the presentation of research results: Respirar adopts these guidelines for each type of study according to the recommendation of the Pan American Health Organization (PAHO) and the EQUATOR network (Enhancing the QUALity and Transparency Of health Research): CONSORT for randomized controlled clinical trial, STROBE for observational studies, CARE for case reports, PRISMA or MOOSE for systematic reviews and meta-analyses, and STARD or TRIPOD for diagnostic/prognostic studies, SPIRIT  or PRISMA-P for study protocols, AGREE or RIGHT for protocols/clinical practice guidelines, COREQ (checklist) or SRQR for qualitative studies, ARRIVE  for preclinical animal studies, SQUIRE for quality improvement studies, and CHEERS for economic evaluation.

Systematic reviews and meta-analyses: should be registered in the Próspero database (International Prospective Register of Systematic Reviews) preferably before the eligibility criteria application procedures are initiated. The registration number must appear at the end of the abstract of the article and in the material and methods area. 

Data deposit: Respirar adheres to all open access initiatives, among them, it supports the initiative of the Núcleo Básico de Revistas Científicas Argentinas to require the supporting data of the investigations and their deposit according to ley 26,899, Institutional Digital Opem Access Repositories. This law establishes the obligation of public organizations and institutions that make up the National System of Science, Technology and Innovation (SNCTI), to "develop open access institutional digital repositories, their own or shared, in which the resulting scientific-technological production will be deposited. of work, training and/or projects, fully or partially financed with public funds, of its researchers, technologists, teachers, postdoctoral fellows and master's and doctoral students." After the corresponding deposit, the link must be inserted in the body of the article with the corresponding bibliographical reference. 

2. Instructions for authors

Papers submitted to Respirar must be prepared according to the Instructions for Authors who adhere to the recommendations of the International Committee of Medical Journal Editors (ICMJE). 

The articles are divided into several categories. The specific requirements of each category are presented below, but some aspects are common to all. 

Format

Articles must be supplied in .doc format.It is recommended to use Arial font, size 12 pt and double spaced. 

Writing style

Authors should remember that they are writing for an international, primarily Latin American, audience: clarity is essential. Authors should be concise, not repeat information and, if possible, avoid lengthy explanations or lengthy technical information (these should be presented as figures or tables). 

Front page

The following information should appear on the first page: 

• Type of article
• Full title
• Abbreviated title for page header
• Full names of the authors and their full institutional affiliation
• ORCID identifier of the authors
• Name and email of the corresponding author (with whom correspondence will be maintained).
• Contributions of the authors (identification of responsibility of the author of the content according to the criteria of ICMJE and roles defined in the taxonomy of CRediT- NISO (conceptualization; data curation; formal analysis; funding acquisition; investigation; methodology; project administration; resources; software; supervision; validation; visualization; writing, original draft; writing, review and editing.
• Total number of words in the document 

Work title

The title of the work should be concise, but informative about the main content of the publication and stimulate the interest of the reader. Do not use abbreviations in the title. Add in a separate line an "abbreviated title" of no more than 60 characters (including spaces), which summarizes said title and can be used as "header of pages". 

Abstract in Spanish and English
Original articles, clinical cases, images and reviews must have an abstract in Spanish and another in English that must not exceed 250 words each. It will begin with a title and end with the keywords (between three and six). No tables, figures or references should be mentioned. 

'In the case of original articles, the abstract must be structured (Introduction, Methods, Results and Discussion or Conclusions).

The use of the DeCS (Descriptors in Health Sciences) is recommended for most of the keywords. 

Figures and tables

Authors will be encouraged to include figures, flowcharts, or tables to illustrate their articles. Images, such as photographs, x-rays, etc., must be supplied in .jpg or .tif format, with a resolution of no less than 72 dots per inch (dpi) at their final print size. The images must not be integrated into the document that contains the text of the article, but must be sent in a separate, well-identified document. 

It is important that you identify and explain any symbols, arrows, numbers, or letters that you have used to mark any part of the illustrations. In reproducing slides, make explicit the magnification and staining methods. Explain at the bottom of the legends the meaning of all the abbreviations used. 

References

The references will be Vancouver style, they must be limited to the necessary and essential ones (50 or less) in the majority of the cited publication categories as shown below:

Reference type	How to quote
For journal articles	Bannerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004; 23: 685–692. Doi: 10.1183/09031936.04.00056804
Chapters of books	Bourbon J, Henrion–Caude A, Gaultier C. Molecular basis of lung development. In: Gibson GJ, Geddes DM, Costable U, Sterk PJ, Corrin B, eds. Respiratory Medicine. 3rd ed. Elsevier Science, Edinburgh/Philadelphia, 2002; pp. 64–81.
Websites	Websites can be listed in the bibliography, but not among the texts, and should be used only when the original to be cited is inaccessible by other means: WHO. Severe Acute Respiratory Syndrome (SARS). [Internet]. [Accessed 2012 Jul 3]. Available at: www.who.int/csr/sars/en/index.html.
Forthcoming and Preprints	Barr DZ, Atkatsh K, Tavarez U, Erdos MR, Gruenbaum Y, Collins FS. Biotinylation by antibody recognition- A novel method for proximity labeling. BioRxiv 069187 [Preprint]. 2016 [Accessed 2017 Jan 12]. Available at: https://www.biorxiv.org/content/10.1101/069187v1
Dataset	Kraemmer MUG, Sinka ME, Duda KA et al. The global compendium of Aedes aegypti and Ae. albopictus occurrence [dataset]. 2015 Jun 30 [Accessed 2015 Oct 23]. Dryad Digital Repository. Available at: https://datadryad.org/stash/dataset/doi:10.5061/dryad.47v3c Referenced in doi: 10.7554/eLife.08347
Software	Hayes B, Tesar B, Zurow K. OTSoft: Optimality Theory Software. Version 2.3.2 [software]. 2013 Jan 14 [Accessed 2015 Feb 14]. Available at: https://linguistics.ucla.edu/people/hayes/otsoft/.

 

When an article has more than six authors, the first three will be mentioned followed by the expression et al.

The names of the journals will be abbreviated according to the style used in the Index Medicus. The list can be obtained at: http://www.nlm.nih.gov

In all references, the DOI must be indicated if available. 

Units

International units [MOU2] must be used and these must be clearly indicated in the text, figures and tables.

Types of articles published

Respirar initially considers the following types of articles: Original Articles; Reviews; Clinical Cases; Images of Respiratory Pathology; Brief Communications; Editorials and Letters to the Editor, each of which has its own characteristics.

1. Original Articles

Original articles must not exceed 3,000 words (excluding references, tables and figures) and will be divided into: a) Introduction: It will summarize the background that gives rationality or relevance to the study and in the final part the objectives of the work will be presented without anticipating results or conclusions. b) Materials and methods: the subjects studied will be described; the methods, apparatus and procedures used; statistical analysis, ethical guidelines or standards followed. c) Results: they must be clear and concise, not repeat what is already indicated in figures or tables. d) Discussion: the results that emerge from this work will be discussed and linked to other relevant studies on the subject. The findings and limitations of the work and the relationship with the objectives formulated in the introduction will be highlighted. e) Conclusions: brief summary of about two paragraphs summarizing the main points of the article in question. f) Acknowledgments: When appropriate, the authors may thank people or institutions that have made substantive contributions to the work. The consent of the named persons will be the responsibility of the authors.

2. Reviews

Review articles should not exceed 3,000 words (excluding references, tables, and figures). When reviewing a topic, its importance should be explained and a summary of the most representative works that have already been published on that topic should be made.

3. Clinical Cases

Cases should be chosen for their clinical importance and not just for their rarity. They should not exceed 1,500 words (excluding references, tables and figures) and full use should be made of complementary studies, measurements, laboratory results and images of diagnostic tests. References should be limited to what is essential.

4. Images of Respiratory Pathology

With a maximum of three images and 1500 words, the images submitted must be illustrative, original and have the authorizations of the patient. The presentation format includes a description of the clinical case and a discussion that does not exceed 660 words. References should be limited to what is essential.

5. Brief Communications

Brief Communications correspond to final or preliminary results that, due to their interest, justify early dissemination. Due to their length, they will not be divided into sections. These articles will have a maximum of eight pages, 15 references and two Tables or Figures. The publication of Brief Communications will take place in a period of less than three months from its acceptance.

6. Editorials

Editorial comments are usually requested by the Editorial Board to update an important issue or to discuss or comment on the news or controversies of an original work published in Respirar. They should not exceed 1500 words and 20 references.

7. Letters to the Editor

The section Letters to the Editor is designed to give readers the opportunity to carry out a structured discussion or comment on one of the clinical cases or article commented on in previous editions of the journal. The analysis should be short (less than 300 words) and structured. This must include the title of the case or article to be commented on, details of its publication, and provide a documented reasoning for the discussion, such as the reason why it occurs, or the area of ​​controversy. References should be limited to essential citations.

(Last update 2024.4.26)